- Home
- NBY vs NUWE Comparison
NBY vs NUWE Comparison
Compare NBY & NUWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBY
- NUWE
- Stock Information
- Founded
- NBY 2000
- NUWE 1999
- Country
- NBY United States
- NUWE United States
- Employees
- NBY N/A
- NUWE N/A
- Industry
- NBY
- NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- NBY
- NUWE Health Care
- Exchange
- NBY Nasdaq
- NUWE Nasdaq
- Market Cap
- NBY 3.5M
- NUWE 3.9M
- IPO Year
- NBY 2007
- NUWE N/A
- Fundamental
- Price
- NBY $0.60
- NUWE $0.23
- Analyst Decision
- NBY Strong Buy
- NUWE Strong Buy
- Analyst Count
- NBY 1
- NUWE 1
- Target Price
- NBY $0.85
- NUWE $17.00
- AVG Volume (30 Days)
- NBY 32.1K
- NUWE 30.9M
- Earning Date
- NBY 08-12-2025
- NUWE 08-12-2025
- Dividend Yield
- NBY N/A
- NUWE N/A
- EPS Growth
- NBY N/A
- NUWE N/A
- EPS
- NBY 0.57
- NUWE N/A
- Revenue
- NBY $9,781,000.00
- NUWE $8,787,000.00
- Revenue This Year
- NBY $23.91
- NUWE $6.53
- Revenue Next Year
- NBY $32.05
- NUWE $51.63
- P/E Ratio
- NBY $1.33
- NUWE N/A
- Revenue Growth
- NBY 20.52
- NUWE N/A
- 52 Week Low
- NBY $0.36
- NUWE $0.21
- 52 Week High
- NBY $2.47
- NUWE $6.61
- Technical
- Relative Strength Index (RSI)
- NBY 53.58
- NUWE 26.12
- Support Level
- NBY $0.56
- NUWE $0.21
- Resistance Level
- NBY $0.64
- NUWE $0.32
- Average True Range (ATR)
- NBY 0.03
- NUWE 0.07
- MACD
- NBY -0.00
- NUWE 0.00
- Stochastic Oscillator
- NBY 44.44
- NUWE 11.43
About NBY NovaBay Pharmaceuticals Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.
About NUWE Nuwellis Inc.
Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.